NK

Nabeel Khan

Active Director Director DIN 10113510
DIN 10113510 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Nabeel Khan

Data last updated:

Nabeel Khan is a Director at Afronile Healthcare Private Limited (since 2023). Afronile Healthcare Private Limited reported revenue of ₹4.99 Cr (FY 2025).

DIN 10113510
Primary Designation Director
First Appointment 12 Apr 2023
Oldest Company Age 3 yrs
Largest company Afronile Healthcare Private Limited · ₹4.99 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Afronile Healthcare Private Limited U86201DL2023PTC412414
Director12 Apr 20232023₹4.99 Cr (FY 2025)Active

Board colleagues of Nabeel Khan

NameDINCompanyDesignation
Salman Raghib10350185Afronile Healthcare Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Afronile Healthcare Private Limited
Premium access

Shareholding and investment profile for Nabeel Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nabeel Khan

Nabeel Khan currently holds 1 directorship: Afronile Healthcare Private Limited (Director, since 12 Apr 2023, revenue ₹4.99 Cr (FY 2025)).

Nabeel Khan was first appointed on 12 Apr 2023 as Director at Afronile Healthcare Private Limited.

The current boards of Nabeel Khan's companies include Salman Raghib (Afronile Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available